Posts Tagged ‘lung cancer’

Interviews with Dr Veronique Desaulniers (breast cancer) and Dr Carl O Helvie (lung cancer) now Available.

Sunday, January 4th, 2015

DrVpictureDr Veronique has been in practice since 1979 and has written Heal Breast Cancer Naturally a best selling book on Amazon based upon her experience with breast cancer.  She discusses her 7 essential step coaching program to heal any chronic disease. More information is available earlier on this site or at:



Dr Carl O Helvie has been a nurse practitioner, author, researcher and educator for 60 years, has published 8 books and 4 additional book chapters including one best seller book You Can Beat Lung Cancer:Using Alternative/Integrative Interventions, hosts the Holistic Health Show on BBS Radio and is Founder and President of the Carl O Helvie Holistic Cancer Foundation. He has been listed in most nation references,  was awarded the Distinguished Career Award from the American Public Health Assn and is listed in Wikipedia. More information at: Http:// or

Enjoy the Interviews Below:



Is Smoking Associated with an Increased Risk of Developing a Second Smoking-Related Cancer?

Wednesday, November 19th, 2014


A new study published in the J of Clinical Oncology that analyzed five large prospective cohort studies reported that lung cancer (stage 1) bladder, kidney., and head and neck cancer survivors who smoked 20 or more cigarettes a day prior to their cancer diagnosis have an up to five-fold higher risk of developing a second smoking-related cancer when compared to survivors of the same cancer who never smoked. This association of smoking and 2nd cancer  was similar to smoking and primary cancers.

Researc hers said “As survival improves for a number of smoke-related cancers, patients are living longer, however,, smoking may increase the risk of developing a second smoking-related cancer among these survivors.” They continued on to say that health care professionals should emphasize the importance of smoking-cessation to all patients, including cancer survivors.

Data for these results included 5 prospective studies which included 2,552 patients with stage 1 lung, 6.386 with bladder, 3,179 with kidney, and 2,967 with head and neck cancer.  A total of 866 second primary smoking-related cancers were diagnosed among the survivors and the association between smoking status prior to primary cancer diagnosis and second smoke-associated cancer risk were assessed. In all four groups those who smoked   20 or more cigarettes daily prior to their first diagnoses were more likely to develop aa second smoking-related cancer when compared to the cohort who never smoked. These risks ranged from 3.3 times more like to 5.3 times more like likely depending upon the site of the cancer. In addition, those who were current smokers but smoked under 20 cigarettes a day or former smokers who quit before their first cancer diagnosis also had an elevated risk of developing a second primary cancer than those who never smoked.

Can Lung Cancer Remain Hidden for 20 Years?

Wednesday, October 15th, 2014


A new study published in Science concluded that lung cancer can be dormant for over 20 years before becoming abn aggressive for of cancer. Studying 7 patients who were smokers, never smokers, and ex-smokers they found that after the first genetic mistake that caused the cancer it could exist undetected for many years until new additional faults trigger rapid growth of the disease. Their goal is to improve detection and reduce the devastating effect of lung cancer. The researcher says ” Survival from lung cancer remains devastatingly low with many new targeted treatments making a linited impact 8on the disease. By understanding how it develops we’re opening up the diseases evolutionary ruolwe book in the hope that we can start to predict its next steps.”  New information about smoking and lung cancer was also uncovered and many of the early genetic faults are caused by smoking. However, as the disease progresses these become less important with the majority of faults caused by a new process generating mutations within the tumor controlled by a protein called APOBEC. The researcher said “This fascinating research highlights the need to find better ways to detect lung cancer earlier when it’s still following just one evolutionary path,  If we can nip the disease in the bud and treat it before it has started traveling down different evolutionary routes we could make a real difference in helping more people survive the disease.” More research is planned.

Can Components in Celery Kill Lung Cancer Cells?

Wednesday, October 8th, 2014


A new study published in PubMed concluded that celery killed up to 86 percent of lung cancer cells in vitro. It has also been found effective in killing ovarian, pancreatic, prostate, breast. and liver cancer cells because of the anticancer compound called apigenin. Researchers found that by eating just two medium stalks of celery two or three times a week they could reduce the risk of lung cancer by 60%. However, researchers are not sure if results are due to the apigenin or if it works in coperation with other compounds found in celery. They also said “Apigenin widely inhibits cell proliferation of vartious lung cancer cell lines in a dose-dependent manner and the combination treatment of apigenin and antitumor drugsis very effective in human lung cancer cells, and Nrf2-ARE pathwaymay contribute to the mechanism.” In previous studies they found  “an inverse relationship between vegetable and fruit intake and lung cancer risk in both strata of current and never smokers.” Found also were women who ate plenty of apigenin in their diets were more likely to reduce the risk of developing breast cancer by 1%. and ovarian cancer by 20%. It is believed that apigenin may work by reducing the possibility of cancerous tumors growtrh by decreasing the vascular endothelial and decreasing the glucose uptake–minimizing the cycle of cancer cell formation in the pancreas. the researchers encourage everyone to eat celery but caution people to eat organic because celery is ofter drenched with pesticides.


Non Small Cell Lung Cancer Suppressed by Combining microRNA therapy.

Friday, September 19th, 2014


In a new study published in online journal Oncogene researchers concluded that combining two microRNAs in an animal model of non-small-cell lung cancer suppressed tumor growth. This research may offer a less toxic and more direct method for targeting relevant pathways used by tumor cells. This research supplements clinical trials and pre-clinical models evaluating  single microRNAs as key therapeutic agents for cancer.   Researchers said “Targeted cancer therapies are often used in combination to help offset primary or secondary resistance.” ..We know that microRNAs target many oncogenes, We, therefore, hypothesized that a combination of two miRNAs could similarly offset resistance.”

“Non-small-cell lung cancer (NSCLC) is extremely aggressive, owing to an accumulation of mutations that affect the cancer pathways RAS and p53.” The K-RAS mutation is found in about 25 percent of NSCLC patients, and the p53 mutation is found in about 50 percent of these patients. Researchers said “Our research group and others have found that both of these miRNAs can inhibit tumor growth in a variety of cells and animal model systems when used as therapeutic agents.”  Because tumor formation in the NSCLC model depends on two or more signaling pathways, and because let-7 and miR-34 repress distinct oncogenes, we explored whether combining let-7 and miR-34 into a single therapeutic could be even more effective.” .Half the dose of each was used in cells and in vivo and were well tolerated by animals.

Should Medicare Cover Lung Cancer Screening?

Wednesday, September 17th, 2014


logo1267406_mdA recent study to be published in  the Annals of Internal Medicine and reported by Science Digest concluded that medicare beneficiaries should not be excluded from screening. In the study researchers analyzed the benefits and harm of screening by age and found that even though smoking is the most important risk factor for lung cancer there was a reduction in lung cancer mortality in high risk populations who were randomly assigned to low-dose computed topography (LDCT) verses chest radiography. Age was found to be the most important factor for lung cancer following smoking. Subsequently, the U.S. Preventive Services Task Force recommended annual lung cancer screening with LDCT for people aged 55 to 80 who had ever smoked.

A second study of the data compared screening outcomes among Medicare-eligible people with those under the age of 65. Findings showed that both cancer prevalence and positive predictive value of lung cancer screening with LDCT were higher in the 65 plus group than in the under 65 group.  Researchers recommend sharing the age related findings with data with those in the high risk group (smoking and age factors).

Can a Blood Test Detect All Types of Cancer?

Wednesday, August 6th, 2014


New research published online in FASEB Journal, The U.S.Journal of American Societies for Experimental Biology, concluded that a revolutionary blood test that could detect any type off cancer was developed by British scientists. The test6 has been shown to diagnose cancer and pre-cancerous conditions from blood of patients with melanoma, colon cancer and lung cancer with a high degree of accuracy. Researchers assessed white blood cells and measured the damage caused to their DNA when subjected to different intensities of ultraviolet light that is known to damage DNA. They found a clear distinction between the damage to the white blood cells from patients with cancer, with precancerous conditions, and from healthy patients. They also found that  people with cancer have DNA that is more easily damaged by untraviolet light than other people.

Results were based upon blood samples of 206 people of which 94 were healthy and 114 were patients  in specialist clinics prior to diagnosis and treatment. Ultra violet damage was observed in the form of pieces of DNA being pulled in an electric field toward the positive end of the field, causing a comet like tail. The longer the tail the more the DNA damage and this correlated with patients who were ultimately diagnosed with cancer(58) and precancerous conditions (58) and those who were healthy (94). Further clinical research is evaluating the tests accuracy.

Dr Ben Johnson (skin care) and Dr Carl O Helvie (lung cancer) on Holistic Health Show.

Sunday, July 6th, 2014


Dr Ben Johnson has 17 pending patents and is founder and formulator of Osmosis Pur Medical SkinCare. More information was presented earlier on this site and can be found at:



Dr Carl O Helvie has 60 years experience as a nurse practitioner, educator, author and researcher and has published 8 books and chapters in 4 additional ones. He currently hosts the Holistic Health Show. More information is available at:  and


Enjoy the Interview Below:


Dr Ben Johnson (Medical Skin Care) and Dr Carl O Helvie (Natural Treatment of Lung Cancer) to Be on Holistic Health Show.

Sunday, June 29th, 2014


As a renowned innovator in the world of skin health, Dr. Ben Johnson, MD is the founder and formulator of Osmosis Pür Medical Skincare. With the medical profession being his career choice, Dr. Johnson earned his degree from the Creighton University School of Medicine. Soon after, he discovered a passion in aesthetic medicine spending a decade as the founder of a national medi-spa chain which utilized his first skincare line, Cosmedix.

As a firm believer in practicing what he preached,Dr. Johnson utilized Cosmedix products in his daily regimen. However, he soon realized that a new strategy was needed once he noticed his own skin continued to age in appearance. This being his prime focus, Dr. Johnson went back to the drawing board and spent close to two years formulating what is now known as Osmosis Pür Medical Skincare.

During this journey, he knew that in order to create a revolutionary regimen he needed to challenge the prevailing skincare models to create a new standard. At the time of development, most of the product lines Dr. Johnson examined utilized irritating ingredients that struggled to penetrate the skin. In order to avoid irritation and produce a line that worked for even the most sensitive types, Dr. Johnson infused his products with highly efficacious ingredients and nutrients that promoted skin health and repair. His philosophy holds true to an emphasis on dermal remodeling as opposed to the excessive exfoliation many have preached in the past.

Holding over 17 pending patents, Dr. Johnson continues to be a thought leader and innovator when it comes to reversing the aging process. His Osmosis Pür Medical Skincare line achieves remarkable results by addressing every aspect of skin damage; collagen/elastin production, scar tissue build-up, loss of skin nutrition/ growth factors, and DNA damage. Furthermore, Osmosis’ efficacy stems from the acknowledgement that products must work in partnership with the skin.

With that partnership in mind, Dr. Johnson continues to embrace change and innovation into the skincare arena. He has strategically brought in new technologies including Zinc Finger Technology™, a DNA repair strategy, and liposomally delivered stem cell growth factors amongst others. Dr. Johnson believes that a holistic approach to skincare, which focuses on reversing the aging process, is the only way to change one’s appearance for the better. More information at:


Dr Carl O. Helvie is a registered nurse, with two masters (U of California, Johns Hopkins U) and a doctorate in public health and wellness (Johns Hopkins U) and 60 years experience as a nurse practitioner, educator, author, and researcher who received national recognitions including the Distinguished Career in Public Health Award from the American Public Health Association in 1999 and listings in most major national references including Who’s Who, Who’s Who in Virginia, Who’s Who in American Nursing, Outstanding Educator in America,  Men of Achievement, American Men and Women of Science, and 2 listings in Wikipedia. He has published 8 books and chapters in 4 additional ones. He has also published or presented internationally over 100 papers and articles.  Two of his noted accomplishments are the development and publication of a nursing theory that is used internationally in 9 countries and the establishment of a nursing center that provided primary care for homeless and low-income individuals and families.  He has recently established the Carl O Helvie Holistic Cancer Foundation.  .

Dr Helvie is also a 40-year lung cancer survivor (July, 2014) who was given 6 months to live by conventional medicine so he used natural interventions. His story and what he has done since to prevent recurrence is included in You Can Beat Lung Cancer: Using Alternative/Integrative Interventions. At age 81 he not only beat the odds of lung cancer but also the odds of 3 chronic illnesses and 5 prescribed medications that are the average for a 75 year old. For the past 39 years his focus has been on holistic health and natural interventions. He has been host of the Holistic Health Show on BBS Radio for the past 5 ½  years, has been interviewed on over 150 radio programs, television and in many magazines, and acts as a resource to around 60 cancer patients monthly. More information can be found at: ..  and :




Is the Timing of the First Cigarette of the Day Associated with Lung Cancer Risk?

Friday, June 27th, 2014


A new study published in the Journal of the National Cancer Institute concluded that the timing of the first cigarette of the day may be associated with getting lung cancer in both heavy and light smokers. This factor may be added to standard markers of nicotine dependence that include cigarettes smoked daily, duration of smoking, and cumulative exposure (pack years). Researchers analyzed data on 3249 ever smokers of which 1812 were lung cancer patients.  Those without lung cancer in the sample served as controls and were matched by residence, sex, and age. . The research question was “How soon after you wake up do you usually smoke your first cigarette of the day?” Responses were categorized as: 5 or fewer, 6 to 30 minutes, 31 to 60 minutes and more than 60 minutes. After controlling for smoking intensity, duration and other cancer risk factors, the cancer risk was significantly higher for those who had their first cigarette within a shorter time of rising when compared to those who smoked their first cigarette after 1 hour. This relationship held for both light and heavy smokers, and for current and past smokers but not different between men and women. Researchers concluded that although the data support a signicantly higher risk of lung cancer for those who smoke sooner upon arising there is need for more research to validate these findings.